Mutations in the p53 tumor suppressor gene in colorectal cancer in Taiwan

Kaohsiung Journal of Medical Sciences

Volumn 19, Issue 4, 2003, Pages 151-157

  Chang, Fu Hsin ^a   Tzeng, Dong Sheng ^a   Lee, Tai Min ^a   Chen, Twu Chiang ^a   Hsu, Li Sung ^b   Lung, For Wey ^a  

^a KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b FOOYIN UNIVERSITY   (Taiwan)

Author keywords

Colorectal cancer; P53; Polymerase chain reaction; Sequence; Single strand conformation polymorphism

Indexed keywords

GENOMIC DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; COLORECTAL CANCER; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENETIC IDENTIFICATION; HUMAN; HUMAN TISSUE; MALE; MARKER GENE; POINT MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TAIWAN; TUMOR SUPPRESSOR GENE;

EID: 0038377110     PISSN: 02575655     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1607-551x(09)70464-4     Document Type: Article

References (25)

1. Fearon ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987;328:193-7.
2. Levine AJ. The tumor suppressor genes. Annu Rev Biochem 1993;62:623-51.
3. Vogelstein B. Cancer. A deadly inheritance. Nature 1990;348:681-2.
4. Orita M, Iwahana H, Kanazawa H, et al. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989;86:2766-70.
5. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991;351:453-6.
6. Knudson AG. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 1985;45:1437-43.
7. Rand A, Glenn KS, Alnares CP, et al. p53 functional loss in a colon cancer cell line with two missense mutations (218leu and 248trp) on separate alleles. Cancer Lett 1996;98:183-91.
8. Bunz F, Hwang PM, Torrance C, et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest 1999;104:263-9.
9. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancer. Science 1991;253:49-53.
10. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutation and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874-9.
11. Ogunbiyi OA, Goodfellow PJ, Gagliardi G, et al. Prognostic value of chromosome lp allelic loss in colon cancer. Gastroenterology 1997;113:761-6.
12. Scheffner M, Werness BA, Huibregtse JM, et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-36.
13. Momand J, Zambetti GP, Olson DC, et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992;69:1237-45.
14. Ulrik L, Hanna F, Nikos P, et al. Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma. Cancer 2000;88:2661-7.
15. Yamaguchi K, Sugano K, Fukayama N, et al. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms. Am J Gastroenterol 1997;92:307-12.
16. Cripps KJ, Purdie CA, Carder PJ, et al. A study of stabilization of p53 protein versus point mutation in colorectal carcinoma. Oncogene 1994;9:2739-43.
17. Baker SJ, Preisinger AC, Jessup JM, et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990;50:7717-22.
18. Kikuchi-Yanoshita R, Konishi M, Ito S, et al. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res 1992;52:3965-71.
19. Cornelis RS, van Vliet M, Vos CB, et al. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutation. Cancer Res 1994;54:4200-6.
20. Chang KP, Hao SP, Lin SY, et al. A lack of association between p53 mutations and recurrent nasopharyngeal carcinomas refractory to radiotherapy. Laryngoscope 2002;112:2015-9.
21. McDonald JD, Daneshvar L, Willert JR, et al. Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics 1994;23:229-32.
22. Tang R, Wang PF, Wang HC, et al. Mutations of p53 gene in human colorectal cancer: distinct frameshifts among populations. Int J Cancer 2001;91:863-8.
23. Sigal A, Rotter V. Oncogenic mutations of p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res 2000;60:6788-93.
24. Hou MF, Huang TJ, Huang CJ, et al. Expression of p53 protein and its prognostic significance in breast cancer patients. Kaohsiung J Med Sci 1996;12:471-8.
25. Van Houten VM, Tabor MP, Van Den Brekel MW, et al. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol 2002;198:476-86.